Recombinant cytokine treatment for scleroderma. Can the antifibrotic potential of interferon-gamma be realized clinically?
Varga
J
J
D002986:Clinical Trials as Topic; D005355:Fibrosis / Q000628:therapy; D006801:Humans; D007371:Interferon-gamma / Q000502:physiology / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000627:therapeutic use; D012595:Scleroderma, Systemic / Q000628:therapy*
D011994:Recombinant Proteins; D007371:Interferon-gamma